Atlas Trials

A Clinical Study of Oglemilast in Patients With Mild to Moderate Persistent Asthma

Clinical trial NCT00859404 · UNKNOWN

Trial details

NCT number
NCT00859404
Sponsor
Glenmark Pharmaceuticals Europe Ltd. (R&D)
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma
Start date
2008-10-01
Primary completion
2009-12-01
Enrollment
282

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.